Literature DB >> 15710722

Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease.

H F Alber, M Frick, J Dulak, J Dörler, R-H Zwick, W Dichtl, O Pachinger, F Weidinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710722      PMCID： PMC1768779          DOI： 10.1136/hrt.2003.021311

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

Authors:  D W Losordo; P R Vale; J F Symes; C H Dunnington; D D Esakof; M Maysky; A B Ashare; K Lathi; J M Isner
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

2.  Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease.

Authors:  M Fleisch; M Billinger; F R Eberli; A R Garachemani; B Meier; C Seiler
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

3.  Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.

Authors:  Andrew D Blann; Funmi M Belgore; Charles N McCollum; Stanley Silverman; Peck Lin Lip; Gregory Y H Lip
Journal:  Clin Sci (Lond)       Date:  2002-02       Impact factor: 6.124

4.  Vascular endothelial growth factor enhances atherosclerotic plaque progression.

Authors:  F L Celletti; J M Waugh; P G Amabile; A Brendolan; P R Hilfiker; M D Dake
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

5.  Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease.

Authors:  Hannes Franz Alber; Jozef Dulak; Matthias Frick; Wolfgang Dichtl; Severin Paul Schwarzacher; Otmar Pachinger; Franz Weidinger
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094
  5 in total
  9 in total

1.  Atorvastatin affects several angiogenic mediators in human endothelial cells.

Authors:  Józef Dulak; Agnieszka Loboda; Agnieszka Jazwa; Anna Zagorska; Jacob Dörler; Hannes Alber; Wolfgang Dichtl; Franz Weidinger; Matthias Frick; Alicja Jozkowicz
Journal:  Endothelium       Date:  2005 Sep-Dec

2.  Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography.

Authors:  Mohammad Tajfard; Latiffah A Latiff; Hamid Reza Rahimi; Mohsen Moohebati; Mehdi Hasanzadeh; Ahmad Sarreshtehdar Emrani; Habibollah Esmaeily; Ali Taghipour; Sayed Reza Mirhafez; Gordon A Ferns; Maryam Mardan-Nik; Elham Mohammadzadeh; Amir Avan; Parichehr Hanachi; Majid Ghayour-Mobarhan
Journal:  Mol Cell Biochem       Date:  2017-05-22       Impact factor: 3.396

3.  Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia.

Authors:  Carrie Anna Geisberg; Guisong Wang; Radwan N Safa; Holly M Smith; Brent Anderson; Xu-Yang Peng; Brian Veerkamp; David X Zhao; Dana Blakemore; Chang Yu; Douglas B Sawyer
Journal:  Coron Artery Dis       Date:  2011-12       Impact factor: 1.439

4.  Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden.

Authors:  Barbara ErŽen; Mira Šilar; Mišo Šabovič
Journal:  BMC Cardiovasc Disord       Date:  2014-11-22       Impact factor: 2.298

5.  Prognostic value of VEGF in patients submitted to percutaneous coronary intervention.

Authors:  Catarina Ramos; Patrícia Napoleão; Mafalda Selas; Cláudia Freixo; Ana Maria Viegas Crespo; Miguel Mota Carmo; Rui Cruz Ferreira; Teresa Pinheiro
Journal:  Dis Markers       Date:  2014-07-07       Impact factor: 3.434

6.  Systematic analysis of the gerontome reveals links between aging and age-related diseases.

Authors:  Maria Fernandes; Cen Wan; Robi Tacutu; Diogo Barardo; Ashish Rajput; Jingwei Wang; Harikrishnan Thoppil; Daniel Thornton; Chenhao Yang; Alex Freitas; João Pedro de Magalhães
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150

7.  Correlation between adiponectin, chemerin, vascular endothelial growth factor and epicardial fat volume in patients with coronary artery disease.

Authors:  Qixin Wu; Yuxiang Chen; Song Chen; Xiaoqiu Wu; Weixia Nong
Journal:  Exp Ther Med       Date:  2019-12-05       Impact factor: 2.447

8.  Angiogenic factors in women ten years after severe very early onset preeclampsia.

Authors:  Ingrid P M Gaugler-Senden; Jouke T Tamsma; Chris van der Bent; Ron Kusters; Eric A P Steegers; Christianne J M de Groot
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

9.  Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular Cognitive Impairment.

Authors:  Cameron Isaacs-Trepanier; Mahwesh Saleem; Nathan Herrmann; Walter Swardfager; Paul I Oh; Benjamin I Goldstein; Jane Mitchell; Kim S Sugamori; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.